| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adjuvant therapy in lymphnode positive prostate cancer
|
Schmeller, N.
|
|
1998
|
37 |
2 |
p. 141-144
|
article
|
| 2 |
Adjuvant therapy in lymphnode positive prostate cancer
|
Schmeller, N.
|
|
1998
|
37 |
2 |
p. 141-144
|
article
|
| 3 |
Antiandrogen with drawal syndrome
|
Breul, J.
|
|
1998
|
37 |
2 |
p. 156-158
|
article
|
| 4 |
Antiandrogen with drawal syndrome
|
Breul, J.
|
|
1998
|
37 |
2 |
p. 156-158
|
article
|
| 5 |
BlasenkarzinomTeil 2: Harnableitung
|
Lampel, A.
|
|
1998
|
37 |
2 |
p. 207-220
|
article
|
| 6 |
BlasenkarzinomTeil 2: Harnableitung
|
Lampel, A.
|
|
1998
|
37 |
2 |
p. 207-220
|
article
|
| 7 |
Complete androgen blockade versus monotherapie
|
Altwein, J. E.
|
|
1998
|
37 |
2 |
p. 149-152
|
article
|
| 8 |
Complete androgen blockade versus monotherapie
|
Altwein, J. E.
|
|
1998
|
37 |
2 |
p. 149-152
|
article
|
| 9 |
Development of tumor selection on the basis of pathological staging in clinically localized prostate carcinoma
|
Noldus, J.
|
|
1998
|
37 |
2 |
p. 195-198
|
article
|
| 10 |
Development of tumor selection on the basis of pathological staging in clinically localized prostate carcinoma
|
Noldus, J.
|
|
1998
|
37 |
2 |
p. 195-198
|
article
|
| 11 |
Die Bedeutung des prostataspezifischen Antigens in der Nachsorge beim Prostatakarzinom
|
Hertle, L.
|
|
1998
|
37 |
2 |
p. 170-171
|
article
|
| 12 |
Die Bedeutung des prostataspezifischen Antigens in der Nachsorge beim Prostatakarzinom
|
Hertle, L.
|
|
1998
|
37 |
2 |
p. 170-171
|
article
|
| 13 |
Fundamentals and principles of tissue transfer
|
Jordan, G. H.
|
|
1998
|
37 |
2 |
p. 180-194
|
article
|
| 14 |
Fundamentals and principles of tissue transfer
|
Jordan, G. H.
|
|
1998
|
37 |
2 |
p. 180-194
|
article
|
| 15 |
Indication for nuclear medicine therapy in advanced cancer of the prostate
|
Schoeneich, G.
|
|
1998
|
37 |
2 |
p. 162-166
|
article
|
| 16 |
Indication for nuclear medicine therapy in advanced cancer of the prostate
|
Schoeneich, G.
|
|
1998
|
37 |
2 |
p. 162-166
|
article
|
| 17 |
Intermittent versus continuous androgen blockage
|
Wolff, J. M.
|
|
1998
|
37 |
2 |
p. 153-155
|
article
|
| 18 |
Intermittent versus continuous androgen blockage
|
Wolff, J. M.
|
|
1998
|
37 |
2 |
p. 153-155
|
article
|
| 19 |
Is gene therapy soon going to be used clinically in advanced cancer of the prostate?
|
Gschwend, J. E.
|
|
1998
|
37 |
2 |
p. 172-174
|
article
|
| 20 |
Is gene therapy soon going to be used clinically in advanced cancer of the prostate?
|
Gschwend, J. E.
|
|
1998
|
37 |
2 |
p. 172-174
|
article
|
| 21 |
Leitlinien urologischer Betreuung Querschnittgelähmter
|
|
|
1998
|
37 |
2 |
p. 221-228
|
article
|
| 22 |
Leitlinien urologischer Betreuung Querschnittgelähmter
|
,
|
|
1998
|
37 |
2 |
p. 221-228
|
article
|
| 23 |
Pain therapy and quality of life
|
Harzmann, R.
|
|
1998
|
37 |
2 |
p. 167-169
|
article
|
| 24 |
Pain therapy and quality of life
|
Harzmann, R.
|
|
1998
|
37 |
2 |
p. 167-169
|
article
|
| 25 |
Rekonstruktion von Meatus/Fossa navicularis unter Verwendung von Hautlappentechnik
|
Jordan, G. H.
|
|
1998
|
37 |
2 |
p. 175-179
|
article
|
| 26 |
Rekonstruktion von Meatus/Fossa navicularis unter Verwendung von Hautlappentechnik
|
Jordan, G. H.
|
|
1998
|
37 |
2 |
p. 175-179
|
article
|
| 27 |
Therapy of hormonerefractory cancer of the prostate
|
Bex, A.
|
|
1998
|
37 |
2 |
p. 159-161
|
article
|
| 28 |
Therapy of hormonerefractory cancer of the prostate
|
Bex, A.
|
|
1998
|
37 |
2 |
p. 159-161
|
article
|
| 29 |
The VATER-syndrom – patients in urology
|
Werner, W.
|
|
1998
|
37 |
2 |
p. 203-205
|
article
|
| 30 |
The VATER-syndrom – patients in urology
|
Werner, W.
|
|
1998
|
37 |
2 |
p. 203-205
|
article
|
| 31 |
Transforming growth factor-β1 (TGF-β1) levels in plasma of patients with prostate cancer and benign prostatic hyperplasia (BPH)
|
Lange, I.
|
|
1998
|
37 |
2 |
p. 199-202
|
article
|
| 32 |
Transforming growth factor-β1 (TGF-β1) levels in plasma of patients with prostate cancer and benign prostatic hyperplasia (BPH)
|
Lange, I.
|
|
1998
|
37 |
2 |
p. 199-202
|
article
|
| 33 |
Treatment of progressive, local, advanced cancer of the prostate
|
Niesel, T.
|
|
1998
|
37 |
2 |
p. 145-148
|
article
|
| 34 |
Treatment of progressive, local, advanced cancer of the prostate
|
Niesel, T.
|
|
1998
|
37 |
2 |
p. 145-148
|
article
|
| 35 |
Wann ist mit einer Androgendeprivation zu beginnen?
|
Bex, A.
|
|
1998
|
37 |
2 |
p. 133-134
|
article
|
| 36 |
Wann ist mit einer Androgendeprivation zu beginnen?
|
Bex, A.
|
|
1998
|
37 |
2 |
p. 133-134
|
article
|
| 37 |
What importance does radical prostatectomy have in lymph node-positive cancer of the prostate?
|
Huland, H.
|
|
1998
|
37 |
2 |
p. 138-140
|
article
|
| 38 |
What importance does radical prostatectomy have in lymph node-positive cancer of the prostate?
|
Huland, H.
|
|
1998
|
37 |
2 |
p. 138-140
|
article
|
| 39 |
What is to be done if the margin of resection is positive after radical prostatectomy?
|
Wirth, M.
|
|
1998
|
37 |
2 |
p. 135-137
|
article
|
| 40 |
What is to be done if the margin of resection is positive after radical prostatectomy?
|
Wirth, M.
|
|
1998
|
37 |
2 |
p. 135-137
|
article
|
Journal description